Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
2.760
+0.020 (0.73%)
After-hours: Apr 28, 2026, 5:44 PM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $532.11 million as of April 28, 2026. Its market cap has increased by 66.08% in one year.

Market Cap
532.11M
Enterprise Value
298.22M
1-Year Change
66.08%
Ranking
#3024
Category
Small-Cap
Stock Price
$2.74

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $532.11M, an increase of 552.89%. That is a compound annual growth rate of 9.55%.

History

DateMarket Cap% Change
Apr 27, 2026364.20M-3.24%
Dec 31, 2025376.40M-26.60%
Dec 31, 2024512.80M-15.16%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
Oct 6, 200581.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Ocugen575.48M
Rigel Pharmaceuticals563.83M
ProKidney561.65M
Sutro Biopharma556.49M
AgomAb Therapeutics NV551.70M
Kyverna Therapeutics544.17M
Tectonic Therapeutic539.83M
Adlai Nortye530.00M
Market Cap Rankings